Managing the A1C and Outcomes in Pharmacy
More than 100 million U.S. adults are currently living with a form of diabetes or prediabetes, according to a report released in July 2017 by the Centers for Disease Control and Prevention (CDC). The report reveals that as of 2015, 30.3 million or 9.4% of the U.S. population have diabetes. Another 84.1 million have prediabetes, a condition that if not treated often leads to type 2 diabetes within five years. Unfortunately, the majority of those with prediabetes do not know they have it. Diabetes is an evolving disease and the incidence increases with age. Therefore, it may eventually touch every one of us in some way. It is a complex, chronic disease that requires a multifaceted approach of management from the healthcare ecosystem, starting with testing.
The A1C Test
The A1C Test is a critical blood test that shows the picture of a patient’s average blood glucose level over the past three months. It determines where a person is sitting on the diabetic scale. This test is used to diagnose type 2 diabetes (making up 90% of diabetes) and prediabetes. Diabetes is often present without symptoms, yet the patient may exhibit risk factors, such as high cholesterol, heart disease, obesity, or family history that warrants testing. And, with the onslaught of processed food, sedentary lifestyles, and fast-paced living, who can afford not to be tested? The A1C can be tracked over time to monitor the patient’s potential for developing diabetes. Or, if the patient has diabetes, the A1C result